Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.
The program will allow certain Medicare enrollees access to GLP-1 drugs for just $50 a month.
The existence of duplicative discounts in the Bridge Program likely represents an unintended consequence of its design that ...
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and ...
Add Yahoo as a preferred source to see more of our stories on Google. A new Medicare GLP-1 Bridge program will offer select weight loss medications for just $50 per month, a fraction of their usual ...